IonQ (NYSE:IONQ) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...

In the last three months, 4 analysts have published ratings on Veritone (NASDAQ:VERI), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of ...

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Celldex Therapeutics CLDX in the last three months. The following table summarizes their recent ...

10 analysts have expressed a variety of opinions on Crocs (NASDAQ:CROX) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ...